This study assessed the phagocytosis of polymorphonuclear neutrophils and the opsonic capacity of serum in experimental human gingivitis. Relationships were sought among these two measurements, clinical indices of gingivitis and complement-related opsonins. Measurements of chemiluminescence provided an index of phagocytosis and of opsonic capacity. Test group Plaque Index scores were higher than the control group on Days 7, 14, and 21, while the Gingival Index of the test group was elevated only on Day 21. Phagocytosis of test subjects' PMNs and opsonic capacity of their sera were no different from that of the controls'. Levels of C3 in both nonactivated and activated sera of the test group were significantly lower than that of the control group only on Day 14. In the test group, differences of per cent C3 conversion occurred between Days 14 and 21, and Plaque Index scores were inversely correlated with the order of per cent C3 data on these same days. Our results also indicate that complement contributes significantly to the serum opsonic capacity. The levels of developing plaque and subsequent gingival inflammation are apparently related to the degree of complement activation.

Download full-text PDF

Source
http://dx.doi.org/10.1902/jop.1987.58.3.177DOI Listing

Publication Analysis

Top Keywords

opsonic capacity
16
test group
16
plaque scores
8
control group
8
group
6
test
5
relationships serum
4
serum opsonins
4
opsonins complement
4
complement human
4

Similar Publications

is ranked among the top five bacterial pathogens responsible for catheter-associated urinary tract infections, wound infections, secondary root canal infections, and infective endocarditis. Previously, we showed that inactivation of either the manganese- and iron-binding (EfaA) or zinc-binding (AdcA and AdcAII) lipoproteins significantly reduced virulence. Here, we explored whether immunization using a multi-valent approach induces protective immunity against systemic enterococcal infections.

View Article and Find Full Text PDF

A new and more effective tuberculosis (TB) vaccine is urgently needed, but development is hampered by the lack of validated immune correlates of protection. Bacillus Calmette Guérin (BCG) vaccination by the aerosol (AE) and intravenous (IV) routes has been shown to confer superior levels of protection from challenge with Mycobacterium tuberculosis (M.tb) in non-human primates (NHP) compared with standard intradermal (ID) administration.

View Article and Find Full Text PDF

Naturally occurring diabetes mellitus (NODM) is one of the most common endocrine disorders in dogs and its etiology closely resembles type 1 diabetes mellitus (T1DM) in people. Human patients with T1DM commonly have cellular derangements consistent with inflammation, impaired immune function, and hypovitaminosis D. There is little information available regarding inflammatory biomarkers, immune function, and vitamin D status in diabetic dogs.

View Article and Find Full Text PDF
Article Synopsis
  • Immune responses during pneumococcal carriage help protect against Streptococcus pneumoniae colonization and infection, with a study measuring specific IgG levels and opsonic titers in adults with and without type 2 diabetes.
  • The study included 176 samples, with findings showing similar IgG concentrations against various serotypes for both groups but higher opsonic titers in non-diabetic individuals, particularly for serotypes 19F and 9V.
  • The results suggest that while antibody production is comparable for both capsular polysaccharide and protein antigens in diabetic and non-diabetic individuals, the functional protective capacity of these antibodies differs significantly between the two groups.
View Article and Find Full Text PDF

Self-assembled monovalent lipidated mannose ligand as a standalone nanoadjuvant.

Vaccine

October 2024

School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia. Electronic address:

Article Synopsis
  • Subunit vaccines need adjuvants to stimulate an immune response, but current options often have safety concerns or limited effectiveness.
  • This study tested mannose-lipopeptide ligands as a potential way to enhance the immune response to a vaccine using a specific Group A Streptococcus (GAS) antigen.
  • The results showed that a particular mannose ligand significantly increased the production of protective antibodies without the negative side effects associated with traditional adjuvants, indicating its potential as a safer vaccine enhancer.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!